Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190024/S014

CINtec PLUS Cytology

Ventana Medical Systems, Inc. · Decision date Jul 31, 2025

FDA DECISIONP190024/S014

What did the FDA approve?

FDA records P190024/S014 as a supplement to PMA P190024, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 31, 2025.

FDA approval order statement

Approval for changes to the concentration of a device component.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Pathology
Decision date
Jul 31, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P190024/S014
Regulatory pathway
PMA supplement
Product code
QKF
Decision code
APPR
Decision date
Jul 31, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Immunocytochemistry assay, p16/Ki-67.

Product code
QKF
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190024/S014 received

    Application receipt date recorded by FDA.

  2. P190024/S014 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P190024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190024

Product / regulatory recordCompanyPathwayDecision dateSource
Ventana Medical Systems, Inc.PMA supplementSep 4, 2025FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Ventana Medical Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1910 E. Innovation Park Dr., Tucson, AZ, 85755

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records